Zota Health Care Invests ₹4.04 Crore in Subsidiary Curexis Ventures Rights Issue
Zota Health Care Ltd · Others (Uncategorized) · 01 Oct 2026, 5:43 pm
Zota Health Care Invests ₹4.04 Crore in Subsidiary Curexis Ventures Rights Issue Zota Health Care acquired 2,020,000 equity shares of its wholly owned subsidiary, Curexis Ventures Private Limited, via a rights issue on 1st Oct'26 for ₹4.04 crore (₹20 per share, including a ₹10 premium). Curexis, incorporated on 25th Feb'25 and operator of retail pharmacy brand "SKIA", reported a turnover of ₹1.18 lakh in FY26. Issue proceeds will be utilized to repay unsecured loans availed from Zota Health Care, reducing consolidated group debt and improving overall net worth while maintaining Curexis as a wholly owned subsidiary.
Original exchange filing (PDF)
More announcements from Zota Health Care Ltd
- Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raised through Qualified Institutional Placement for the quarter ended September 30, 2026 · 14 Nov 2026
- ZOTA: Zota Health Care Limited has informed the Exchange about Transcript of Earnings Conference Call on Financial Results for the quarter ended September 30, 2026 · 04 Nov 2026
- ZOTA: Zota Health Care Limited has informed the Exchange about Audio Recording Link of Earnings Conference Call on financial results for the quarter and half year ended September 30, 2026 · 29 Oct 2026
- Zota Health Care LImited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 28 Oct 2026
- Zota Health Care LImited has informed the Exchange about Investor Presentation · 28 Oct 2026
- ZOTA: Zota Health Care Limited has informed the Exchange regarding a press release dated October 28, 2026, titled "ZOTA: Zota Health Care Limited has informed the Exchange regarding a press release dated October 28, 2026, titled "Zota Health Care Limited Reports Healthy Q2FY27 Performance, Amid Planned Moderation in Store Expansion." · 28 Oct 2026
- ZOTA: Zota Health Care Limited has submitted to the Exchange the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026 · 28 Oct 2026
- ZOTA: Zota Health Care Limited has informed the Exchange about the Intimation of Schedule of Earnings Conference Call on Q2FY27 Results · 29 Oct 2026
